Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.80)
# 3,305
Out of 5,157 analysts
9
Total ratings
40%
Success rate
7.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $26.00 | - | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $29.18 | +64.50% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $12.68 | -5.36% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.48 | +237.84% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $26.00
Upside: -
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $29.18
Upside: +64.50%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $12.68
Upside: -5.36%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.48
Upside: +237.84%